RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Austin, TX · Cypress, TX · +110 more sites
Migraine clinical trials in Austin, TX
15 recruiting migraine studies with a site in Austin, TX.
RecruitingPhase 4NCT07609914
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
Sponsor: Pfizer
Austin, TX · Dallas, TX · Lake Jackson, TX · +18 more sites
RecruitingPhase 3NCT07729462
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
Sponsor: Pfizer
Austin, TX · Dallas, TX · +16 more sites
RecruitingPhase 3NCT07816367
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Austin, TX · Beaumont, TX · Dallas, TX · +69 more sites
RecruitingPhase 3NCT06810505
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Sponsor: AbbVie
Austin, TX · Houston, TX · Waxahachie, TX · +29 more sites
RecruitingPhase 2NCT07646613
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
Sponsor: Aspeya, Inc.
Austin, TX · Dallas, TX · +18 more sites
RecruitingPhase 3NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Sponsor: AbbVie
Austin, TX · El Paso, TX · +39 more sites
RecruitingPhase 2NCT07616128
Study of EVO756 in Adults With Migraine
Sponsor: Evommune, Inc.
Austin, TX · Dallas, TX · Houston, TX · +30 more sites
RecruitingPhase 3NCT04649242
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Sponsor: Pfizer
Austin, TX · +166 more sites
RecruitingPhase 3NCT04743141
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Sponsor: Pfizer
Austin, TX · +112 more sites
RecruitingNot applicableNCT05889624
Responding With Evidence and Access for Childhood Headaches
Sponsor: Children's Hospital Medical Center, Cincinnati
Austin, TX · +14 more sites
RecruitingPhase 3NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor: AbbVie
Austin, TX · +122 more sites
RecruitingPhase 3NCT07645924
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Austin, TX · Cypress, TX · +110 more sites
RecruitingPhase 3NCT06641466
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Sponsor: Pfizer
Austin, TX · Dallas, TX · +30 more sites
RecruitingPhase 2NCT06602479
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Sponsor: AbbVie
Austin, TX · +15 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.